Is second-line anti-tuberculosis drug susceptibility testing reliable?

被引：1

作者：

Kim, SJ ^{[1
]}

Espinal, MA

Abe, C

Bai, GH

Boulahbals, F

Fattorinit, L

Gilpin, C

Hoffner, S

Kam, KM

Martin-Casabona, N

Rigouts, L

Vincent, V

机构：

[1] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland

[2] Japan Anti TB Assoc, Res Inst TB, Tokyo, Japan

[3] Korea Natl TB Assoc, Korean Inst TB, Seoul, South Korea

[4] Inst Pasteur Algerie Alger, Lab TB, Algiers, Algeria

[5] Inst Super San Lab Bacteriol & Med Mycol, Rome, Italy

[6] Prince Charles Hosp, Queensland Mycobacterium Reference Lab, Brisbane, Qld 4032, Australia

[7] Swedish Inst Infect Dis Control, Solna, Sweden

[8] Dept Hlth, TB Reference Lab, Hong Kong, Hong Kong, Peoples R China

[9] Ciudad Sanitaria & Univ Vall Hebron, Serv Microbiol Hosp, E-08035 Barcelona, Spain

[10] Inst Trop Med, Mycobacteriol Unit, Dept Microbiol, B-2000 Antwerp, Belgium

[11] Inst Pasteur, Ctr Natl Reference Mycobacteries, Paris, France

来源：

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：1157 / 1158

页数：2